Mylan N.V., makers of the anti-allergic reaction EpiPen, announced programs Thursday to lower the device's cost after U.S. senators expressed outrage at the price increase.
The single-use auto-injection pens, used as dispensers of the medicine epinephrine in emergencies resulting from food allergies, were created by Merck Group in the 1970s, and were acquired by Mylan in 2007. A price increase, from $57 per pen in 2007 to about $500 per pen today, drew the anger, earlier this week, of four U.S. senators who asked Mylan for an explanation.
EpiPen maker offers patients $300 savings cards
Within months of being soaked with a glyphosate herbicide while working on a cell tower maintenance...
Diary entries released by a Republican senator in an attempt to damage Anthony Fauci also show...
In March in a McDonald's parking lot off a busy Baltimore street, mental health clinician Michala...
The Ebola outbreak in the Democratic Republic of Congo has continued to spread, with the number...
